Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Future Cardiol ; 19(2): 71-76, 2023 02.
Artigo em Inglês | MEDLINE | ID: mdl-36896870

RESUMO

Triple therapy is defined as concurrent use of an anticoagulant and dual antiplatelet therapy. We aimed to review the clinical course of a patient who developed a spontaneous duodenal hematoma on triple therapy and appraise current guidelines regarding triple antithrombotic therapy use. A 59-year-old man presented with acute heart failure and an apical mural thrombus. After medical stabilization, the patient underwent elective coronary stent placement. He was placed on triple antithrombotic therapy and subsequently developed a spontaneous duodenal hematoma. This case describes a rare but potentially fatal complication of triple therapy and underscores the importance of underutilizing this therapy. In conclusion, we report the clinical presentation and management of a rare bleeding complication in a patient on triple therapy.


The use of multiple types of blood-thinning medications is common in patients with blood clots, atrial fibrillation and heart disease, which can increase their risk of bleeding. We present the case of a rare type of gastrointestinal bleeding (a spontaneous duodenal hematoma) that occurred shortly after a patient with new heart failure and a blood clot in the left ventricle was placed on three different types of blood-thinning medications following a cardiac stent procedure. This case highlights the importance of careful management of comorbid cardiac conditions as well as the avoidance of using three blood-thinning medications simultaneously.


Assuntos
Fibrilação Atrial , Intervenção Coronária Percutânea , Masculino , Humanos , Pessoa de Meia-Idade , Inibidores da Agregação Plaquetária/efeitos adversos , Fibrinolíticos/efeitos adversos , Fibrilação Atrial/complicações , Anticoagulantes/efeitos adversos , Hematoma/induzido quimicamente , Hematoma/terapia , Hematoma/complicações , Quimioterapia Combinada
2.
J Am Coll Cardiol ; 78(3): 216-229, 2021 07 20.
Artigo em Inglês | MEDLINE | ID: mdl-33957239

RESUMO

BACKGROUND: Standardization of risk is critical in benchmarking and quality improvement efforts for percutaneous coronary interventions (PCIs). In 2018, the CathPCI Registry was updated to include additional variables to better classify higher-risk patients. OBJECTIVES: This study sought to develop a model for predicting in-hospital mortality risk following PCI incorporating these additional variables. METHODS: Data from 706,263 PCIs performed between July 2018 and June 2019 at 1,608 sites were used to develop and validate a new full and pre-catheterization model to predict in-hospital mortality, and a simplified bedside risk score. The sample was randomly split into a development cohort (70%, n = 495,005) and a validation cohort (30%, n = 211,258). The authors created 1,000 bootstrapped samples of the development cohort and used stepwise selection logistic regression on each sample. The final model included variables that were selected in at least 70% of the bootstrapped samples and those identified a priori due to clinical relevance. RESULTS: In-hospital mortality following PCI varied based on clinical presentation. Procedural urgency, cardiovascular instability, and level of consciousness after cardiac arrest were most predictive of in-hospital mortality. The full model performed well, with excellent discrimination (C-index: 0.943) in the validation cohort and good calibration across different clinical and procedural risk cohorts. The median hospital risk-standardized mortality rate was 1.9% and ranged from 1.1% to 3.3% (interquartile range: 1.7% to 2.1%). CONCLUSIONS: The risk of mortality following PCI can be predicted in contemporary practice by incorporating variables that reflect clinical acuity. This model, which includes data previously not captured, is a valid instrument for risk stratification and for quality improvement efforts.


Assuntos
Doença da Artéria Coronariana/mortalidade , Intervenção Coronária Percutânea , Sistema de Registros , Medição de Risco/métodos , Idoso , Doença da Artéria Coronariana/cirurgia , Feminino , Seguimentos , Mortalidade Hospitalar/tendências , Humanos , Masculino , Período Pré-Operatório , Reprodutibilidade dos Testes , Estudos Retrospectivos , Fatores de Risco , Taxa de Sobrevida/tendências , Fatores de Tempo , Estados Unidos/epidemiologia
3.
Retina ; 38(9): 1688-1698, 2018 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-28723845

RESUMO

PURPOSE: Ophthalmologists serve an increasing volume of a growing elderly population undergoing increasingly complex outpatient medical care, including extensive diagnostic testing and treatment. The resulting prolonged patient visit times ("patient flow times") limit quality, patient and employee satisfaction, and represent waste. Lean Six Sigma process improvement was used in a vitreoretinal practice to decrease patient flow time, demonstrating that this approach can yield significant improvement in health care. METHODS: Process flow maps were created to determine the most common care pathways within clinic. Three months' visits from the electronic medical record system, which tracks patient task times at each process step in the office were collected. Care tasks and care pathways consuming the greatest time and variation were identified and modified. Follow-up analysis from 6 weeks' visits was conducted to assess improvement. RESULTS: Nearly all patients took one of five paths through the office. Patient flow was redesigned to reduce waiting room time by having staff members immediately start patients into one of those five paths; staffing was adjusted to address high demand tasks, and scheduling was optimized around derived predictors of patient flow times. Follow-up analysis revealed a statistically significant decline in mean patient flow time by 18% and inpatient flow time SD by 4.6%. Patient and employee satisfaction scores improved. CONCLUSION: Manufacturing industry techniques, such as Lean and Six Sigma, can be used to improve patient care, minimize waste, and enhance patient and staff satisfaction in outpatient clinics.


Assuntos
Instituições de Assistência Ambulatorial/normas , Eficiência Organizacional , Oftalmopatias/terapia , Oftalmologia , Satisfação do Paciente , Gestão da Qualidade Total , Fluxo de Trabalho , Humanos , Unitiol
4.
Acad Emerg Med ; 24(7): 867-874, 2017 07.
Artigo em Inglês | MEDLINE | ID: mdl-28453186

RESUMO

OBJECTIVE: Focused cardiac ultrasound (FOCUS) is a useful tool in evaluating patients presenting to the emergency department (ED) with acute dyspnea. Prior work has shown that right ventricular (RV) dilation is associated with repeat hospitalizations and shorter life expectancy. Traditionally, RV assessment has been evaluated by cardiologist-interpreted comprehensive echocardiography. The primary goal of this study was to determine the inter-rater reliability between emergency physicians (EPs) and a cardiologist for determining RV dilation on FOCUS performed on ED patients with acute dyspnea. METHODS: This was a prospective, observational study at two urban academic EDs; patients were enrolled if they had acute dyspnea and a computed tomographic pulmonary angiogram without acute disease. All patients had an EP-performed FOCUS to assess for RV dilation. RV dilation was defined as an RV to left ventricular ratio greater than 1. FOCUS interpretations were compared to a blinded cardiologist FOCUS interpretation using agreement and kappa statistics. RESULTS: Of 84 FOCUS examinations performed on 83 patients, 17% had RV dilation. Agreement and kappa, for EP-performed FOCUS for RV dilation were 89% (95% confidence interval [CI] 80-95%) and 0.68 (95% CI 0.48-0.88), respectively. CONCLUSIONS: Emergency physician sonographers are able to detect RV dilation with good agreement when compared to cardiology. These results support the wider use of EP-performed FOCUS to evaluate for RV dilation in ED patients with dyspnea.


Assuntos
Cardiologia/estatística & dados numéricos , Dispneia/etiologia , Medicina de Emergência/estatística & dados numéricos , Hipertrofia Ventricular Direita/diagnóstico por imagem , Disfunção Ventricular Direita/diagnóstico , Centros Médicos Acadêmicos/estatística & dados numéricos , Doença Aguda , Idoso , Idoso de 80 Anos ou mais , Ecocardiografia , Serviço Hospitalar de Emergência/estatística & dados numéricos , Feminino , Humanos , Hipertrofia Ventricular Direita/complicações , Masculino , Pessoa de Meia-Idade , Testes Imediatos , Estudos Prospectivos , Reprodutibilidade dos Testes
6.
J Am Coll Cardiol ; 67(10): 1227-1234, 2016 Mar 15.
Artigo em Inglês | MEDLINE | ID: mdl-26965545

RESUMO

In the 2013 American College of Cardiology (ACC)/American Heart Association Guideline (AHA) on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults, low-density lipoprotein cholesterol treatment thresholds have been replaced with a focus on global risk. In this context, we re-examine the need for fasting lipid measurements in various clinical scenarios including estimating initial risk for atherosclerotic cardiovascular disease in a primary prevention patient; screening for familial lipid disorders in a patient with a strong family history of premature atherosclerotic cardiovascular disease or genetic dyslipidemia; clarifying a diagnosis of metabolic syndrome so it can be used to make lifestyle counseling more effective; assessing residual risk in a treated patient; diagnosing and treating patients with suspected hypertriglyceridemic pancreatitis; or diagnosing hypertriglyceridemia in patients who require therapy for other conditions that may further elevate triglycerides. Posing a specific question can aid the clinician in understanding when fasting lipids are needed and when nonfasting lipids are adequate.


Assuntos
Doenças Cardiovasculares , Jejum , Lipídeos/sangue , Prevenção Primária/métodos , Medição de Risco , Prevenção Secundária/métodos , Doenças Cardiovasculares/sangue , Doenças Cardiovasculares/epidemiologia , Doenças Cardiovasculares/prevenção & controle , Saúde Global , Humanos , Morbidade/tendências , Guias de Prática Clínica como Assunto , Fatores de Risco
7.
Am J Emerg Med ; 33(9): 1178-83, 2015 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-26058890

RESUMO

OBJECTIVES: The goal of this study was to determine if emergency physicians (EPs) can correctly perform a bedside diastology examination (DE) and correctly grade the level of diastolic function with minimal additional training in echocardiography beyond what is learned in residency. We hypothesize that EPs will be accurate at detecting and grading diastolic dysfunction (DD) when compared to a criterion standard interpretation by a cardiologist. METHODS: We conducted a prospective, observational study on a convenience sample of adult patients who presented to an urban emergency department with a chief concern of dyspnea. All patients had a bedside echocardiogram, including a DE, performed by an EP-sonographer who had 3 hours of didactic and hands-on echocardiography training with a cardiologist. The DE was interpreted as normal, grade 1 to 3 if DD was present, or indeterminate, all based on predefined criteria. This interpretation was compared to that of a cardiologist who was blinded to the EPs' interpretations. RESULTS: We enrolled 62 patients; 52% had DD. Using the cardiology interpretation as the criterion standard, the sensitivity and specificity of the EP-performed DE to identify clinically significant diastolic function were 92% (95% confidence interval [CI], 60-100) and 69% (95% CI, 50-83), respectively. Agreement between EPs and cardiology on grade of DD was assessed using κ and weighted κ: κ = 0.44 (95% CI, 0.29-0.59) and weighted κ = 0.52 (95% CI, 0.38-0.67). Overall, EPs rated 27% of DEs as indeterminate, compared with only 15% by cardiology. For DEs where both EPs and cardiology attempted an interpretation (indeterminates excluded) κ = 0.45 (95% CI, 0.26 to 0.65) and weighted κ = 0.54 (95% CI, 0.36-0.72). CONCLUSION: After limited diastology-specific training, EPs are able to accurately identify clinically significant DD. However, correct grading of DD, when compared to a cardiologist, was only moderate, at best. Our results suggest that further training is necessary for EPs to achieve expertise in grading DD.


Assuntos
Competência Clínica , Medicina de Emergência/normas , Insuficiência Cardíaca/classificação , Insuficiência Cardíaca/diagnóstico por imagem , Testes Imediatos , Cardiologia , Diástole , Dispneia/etiologia , Serviço Hospitalar de Emergência/normas , Feminino , Insuficiência Cardíaca/fisiopatologia , Humanos , Masculino , Pessoa de Meia-Idade , Estudos Prospectivos , Ultrassonografia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...